Natural Killer activating Multimeric Immunotherapeutic compleXes (NaMiX) induce cytotoxic activity and killing of HIV-1 infected cells
R. Schober, B. Brandus, T. Laeremans, G. Iserentant, G. Dessilly, J. Zimmer, M. Moutschen, J. L. Aerts, X. Dervillez, C. Seguin-Devaux
This study develops NaMiX, multimeric immunotherapeutics targeting NK cell checkpoints, which enhance NK cell cytotoxicity against HIV-1 infected cells and reduce viral DNA in mice.
bioRxiv · Nov 11, 2022 · PreprintImmunology